Video

Marilyn Tavenner on the Presidential Candidates' Healthcare Strategies

Marilyn Tavenner, president and CEO of America’s Health Insurance Plans, believes that while the tone of this year’s presidential election race has been interesting, the discussion among the candidates regarding issues of healthcare and coverage have generally been the same as elections in years past.

Marilyn Tavenner, president and CEO of America’s Health Insurance Plans, believes that while the tone of this year’s presidential election race has been interesting, the discussion among the candidates regarding issues of healthcare and coverage have generally been the same as elections in years past.

Transcript (slightly modified):

How much does a presidential election weigh on the minds of AHIP’s members? And is this election any different?

Well I think every time there’s an election, members are looking to see what is going to be the healthcare strategy of the presidential candidate. In this case, I think that we understand if you’re talking about Secretary Clinton, she’s been pretty clear about continuing to grow the ACA, making some improvements in the ACA, dealing with delivery system reform. Likewise, for Donald Trump, there’s been less detail but certainly there’s a Republican house we work closely with and they are in the process of putting together principles around healthcare strategy and many of those we endure such as delivery system reform and continuing coverage and quality improvements.

So probably not a lot different than — while the tone of this election’s certainly been more interesting, probably the issues are the same.

Related Videos
AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo